RISCONAPOSTOLUS
← All twelve projects

18-2 · Patient safety · 2026-11-14

Medication Administration and Dispensing Safety

ComputationalSynthetic checks matchedEvaluation data partly established

Evaluate pill identification and prescription checks independently, then verify the evidence behind each error flag.

Research question and target

Define reference cases for pill identification and prescription review, covering lighting, occlusion, look-alike products and unit conversion errors.

Internal target
Zero missed contraindications or look-alike medication errors
Programme
Patient safety
Evidence on this record
Synthetic harness (dispense18)Common synthetic checks

Evaluation data

Evaluation registry · Labels and split definitions (KR)

Synthetic harness · dispense18

Dispensing audit kernel: pill verification and DUR cross-check

Across 6 kinds of injected error, 4,500 cases in all, 0 passed automatically; one-sided 95% upper bounds on the miss rate range from 0.20% to 0.75%. Of 3,000 correct fills, 1,859 (62.0%) passed automatically and the rest went to forced pharmacist review. Vision outputs were simulated; no image inference was run.

Look-alike swap
0 of 1,500 passed; upper bound 0.20%
Random swap
0 of 1,000 passed; upper bound 0.30%
Item from outside the gallery
0 of 600 passed; upper bound 0.50%; Gate B alone would have passed 220
Count error
0 of 400 passed; upper bound 0.75%
Order that breaks a rule
0 of 600 passed; upper bound 0.50%
Order that cannot be judged
0 of 400 passed; upper bound 0.75%
Correct fills
1,859 of 3,000 passed automatically (62.0%); 1,141 sent to forced review
Rule verdicts checked against an oracle
22,410 cases; 27,000 monotonicity pairs
Fault combinations enumerated
50,400
Boundary cases with hand-written expectations
66
Audit trail
68 retained records; 10,200 bulk decisions chained and replayed by the audit
Drift monitor, noise doubled
latched at case 342 after a change at 300; 22 automatic passes in between, 0 of them wrong fills

Limits

Synthetic inputs only (synthetic_only). These figures come from a synthetic gallery, simulated vision outputs and orders written in abstract codes. No pill image was analysed, no real prescription or DUR rule table was used, clinical performance was not assessed and no auditor has signed the result. A separate audit program passed 4 of 4 gates.

G1 · Frozen inputs and submission structureG2 · Completeness of rules, fault transitions and the audit trailG3 · Independent recalculation of thresholds and benchmark verdictsG4 · Virtual metric verdict and result hash

Audit record (JSON) · Run output (JSON) · 18-2 design specification: pill verification and DUR cross-audit software (KR) · 18-2 harness modules and replay record (KR) · 8-1 and 18-2 cross-model review record (KR)

python3 -B -m dispense18.orchestrate --output evidence/dispense18-run.json
python3 -B -m dispense18.audit --run evidence/dispense18-run.json --output evidence/dispense18-audit.json
python3 -B -m unittest discover -s tests -p 'test_dispense18.py' -v

Sources and eligibility

Boundary cases

Common synthetic checks

Expected and observed values for these cases

Review of the attached design

The code attached to this project was reviewed against its claims: synthetic products, unit conversion, sample rules and fixed pill attributes.

5-1 and 18-2 attachment review (KR)

What the official call asks

Infusion over-rate and dispensing errors are separate support areas. Validation at three or more hospitals is required, and stage-two outcomes for the over-rate area include regulatory approval.

Proposal requirements, printed pages 97–100 · All twelve requirements

Interpretation and next evaluation

Report a zero miss rate with the frozen test denominator. Product codes and source rules require verification across medical settings.

Next check
Train the vision modules on the fixed ePillID split, build per-category calibration sets from its validation split and fill the same table on its test split; categories below the minimum calibration size are reported as uncertified with no automatic pass.
← All twelve projects

© 2026 RISCON Co., Ltd.Privacy PolicyTerms of UseCookie SettingsContact

RISCON Labsrisconlabs.com